AI-Powered Robotics & Intelligent Lab Automation Header Image

 





AI-Powered Robotics & Intelligent Lab Automation
Unite Physical and Digital to Build the Intelligent Laboratory of the Future
5/20/2026 - May 21, 2026
Laboratories are no longer defined by stand-alone instruments or isolated automation. In 2026, the focus shifts to connected, computationally aware, and AI-ready lab environments where robotics, data architecture, and digital infrastructure function as a unified system. The AI-Powered Robotics & Intelligent Lab Automation track explores how organizations are integrating robotic workcells, orchestration engines, laboratory data platforms, and cloud/edge computing into end-to-end, interoperable R&D ecosystems. Discussions span connected lab design, multimodal automation, data lineage and metadata frameworks, workflow harmonization, and the governance models required to scale digital and robotic transformation across sites. Speakers will share real-world strategies for building modular, multi-robot environments; preparing laboratory data streams for AI-driven experiment planning; and evolving from human-centric processes to hybrid human–machine scientific operations. Designed for automation engineers, R&D digital leaders, informatics architects, and operations strategists, this track provides the technical, architectural, and organizational playbooks needed to build the intelligent research environments powering next-generation discovery.

Tuesday, May 19

Recommended Pre-Conference Workshops and Symposia*

On Tuesday, May 19, 2026, Cambridge Healthtech Institute is pleased to offer six pre-conference Workshops scheduled across two time slots (9:00 am–12:00 pm and 1:15–4:15 pm) and three Symposia from 8:30 am–3:45 pm. All are designed to be instructional, interactive, and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference tracks that take place Wednesday–Thursday.

*Separate registration required. Additional details:

PLENARY KEYNOTE PROGRAM

Organizer's Remarks

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute , Executive Event Director , Cambridge Healthtech Institute

Presentation to be Announced

Welcome Reception in the Exhibit Hall with Poster Viewing

The Bio-IT Kickoff Reception is a reunion—reconnect with friends, explore cutting-edge research, and celebrate innovation! Enjoy poster presentations, networking, and vote for the Best of Show and Poster awards.

Close of Day

Wednesday, May 20

Bio-IT World’s 5K Rise and Shine Fun Run! (Sponsorship Opportunities Available)

RUN COORDINATORS:
Bridget Kotelly, Senior Conference Director, Cambridge Healthtech Institute
Eileen Murphy, Conference Producer, Cambridge Healthtech Institute

Lace up and join Bio-IT’s Coordinators for the Fun Run on Wednesday, May 20! Sprint, jog, walk, or talk-your-way-through—ALL abilities are welcome. This informal event is all about getting moving together. Full details to come…just don’t forget your sneakers!

Registration and Morning Coffee

PLENARY KEYNOTE PROGRAM

Organizer's Remarks

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

PLENARY KEYNOTE PRESENTATION:
The Collaboration Breakthrough: How Federated Learning Is Rewriting the Rules of Drug Discovery

Photo of Mohammed AlQuraishi, PhD, Assistant Professor, Systems Biology, Columbia University , Assistant Professor , Systems Biology , Columbia University
Mohammed AlQuraishi, PhD, Assistant Professor, Systems Biology, Columbia University , Assistant Professor , Systems Biology , Columbia University
Photo of Jonathan B. Gilbert, PhD, Senior Director, Ecosystem Growth and Contributor Partnerships, Eli Lilly and Company , Sr. Director - Ecosystem Growth and Contributor Partnerships , Eli Lilly and Company
Jonathan B. Gilbert, PhD, Senior Director, Ecosystem Growth and Contributor Partnerships, Eli Lilly and Company , Sr. Director - Ecosystem Growth and Contributor Partnerships , Eli Lilly and Company
Photo of Woody Sherman, PhD, Founder and Chief Innovation Officer, Psivant Therapeutics , Founder and Chief Innovation Officer , Psivant Therapeutics
Woody Sherman, PhD, Founder and Chief Innovation Officer, Psivant Therapeutics , Founder and Chief Innovation Officer , Psivant Therapeutics
Photo of Christina Taylor, PhD, Senior Science Fellow and Computational Molecular Design Lead, Bayer , Senior Science Fellow and Computational Molecular Design Lead , Bayer
Christina Taylor, PhD, Senior Science Fellow and Computational Molecular Design Lead, Bayer , Senior Science Fellow and Computational Molecular Design Lead , Bayer

The pharmaceutical industry sits on a collective treasure trove of proprietary structural biology data, yet competitive concerns have historically prevented the data sharing necessary to train the most powerful AI models for drug discovery. Federated learning is changing this paradigm, enabling biopharma companies to collaborate on AI model training while keeping sensitive data secure and confidential. This plenary session explores the groundbreaking AI Structural Biology (AISB) Network, where industry leaders are pooling proprietary protein-ligand structure data to collaboratively train OpenFold3, an AI model designed to predict molecular interactions with precision approaching X-ray crystallography. Through the federated computing platform, thousands of experimentally determined protein–small molecule structures remain securely at their original locations while contributing to a shared learning framework that no single organization could achieve alone. This session reveals how federated learning solves the industry's most persistent challenge: unlocking collective intelligence while protecting intellectual property. ​Attendees will hear directly from consortium leaders about: 

  • The technical architecture enabling privacy-preserving collaborative AI training across competing organizations 
  • Real-world implementation of federated learning platforms and computational governance frameworks 
  • Strategic rationale for industry collaboration: why sharing model training beats going it alone 
  • Impact and outcomes from early OpenFold3 results in predicting binding affinities and accelerating small molecule discovery 
  • The future of collaborative AI in biopharma, from structural biology to clinical development

Coffee Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)

Start your morning with coffee, connections, and cutting-edge research! Enjoy poster presentations, network in the Exhibit Hall, vote for awards, and a chance at a fabulous raffle prize!

Organizer's Welcome Remarks

BUILDING THE CONNECTED LAB: UNIFYING DATA, AUTOMATION, AND ROBOTIC INFRASTRUCTURE

Chairperson's Remarks

Olga Seltser, Head, Automation & Lab Technology, Dash Bio, Inc. , Head , Automation & Lab Technology , Dash Bio Inc

Architecting Connected Labs across Robotics, Data, and Digital Systems

Photo of David Dambman, Co-Founder & Chief Innovation Officer, LabSync , Co-Founder & Chief Innovation Officer , LabSync
David Dambman, Co-Founder & Chief Innovation Officer, LabSync , Co-Founder & Chief Innovation Officer , LabSync

Presentation to be Announced

Presentation to be Announced

Moderated Panel Discussion with Session Speakers

This panel examines how modern R&D organizations are building connected laboratory environments by integrating robotics, automation platforms, scheduling tools, and data systems. Panelists will discuss practical approaches to achieving interoperability across ELN, LIMS, analytics, and cloud architectures, along with design principles for connected labs, best practices for data lineage and orchestration, and lessons learned from integrating physical and digital research infrastructure at scale.

Moderator Synthesis and Closing Remarks

Transition to Lunch

Refreshment Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)

Bio-IT's hall is bigger than ever; one break won’t cut it! Enjoy dessert and coffee after lunch, explore booths and posters, vote for awards, and participate in our raffle for a chance to win a prize!

ENTERPRISE DIGITAL TRANSFORMATION: ARCHITECTURE, GOVERNANCE, AND CHANGE ACROSS AUTOMATED AND ROBOTIC R&D

Chairperson's Remarks

Jesse Mulcahy, Automation Lead, Genetic Medicine RNA, Eli Lilly & Co. , Automation Lead , Genetic Medicine RNA , Eli Lilly & Co

Governing Digital and Robotic Transformation in Complex R&D Environments

Photo of Jesse Mulcahy, Automation Lead, Genetic Medicine RNA, Eli Lilly & Co. , Automation Lead , Genetic Medicine RNA , Eli Lilly & Co
Jesse Mulcahy, Automation Lead, Genetic Medicine RNA, Eli Lilly & Co. , Automation Lead , Genetic Medicine RNA , Eli Lilly & Co

Organizational Frameworks for Scaling Digital and Robotic Change

John Cesarek, Senior Director of Automation Engineering, Cellares , Senior Director of Automation Engineering , Cellares

Standardizing Data and Workflow Models across Organizational Teams

Photo of Ben Miller, Head, Operations, Leash Bio , Head , Operations , Leash Laboratories
Ben Miller, Head, Operations, Leash Bio , Head , Operations , Leash Laboratories

Modern experimental sciences can generate data faster than teams can analyze and interpret it. We present an automated data analysis system designed to accelerate collaboration between data scientists and laboratory scientists. By integrating experiment design, and analysis into a unified workflow, we shorten iteration cycles, improve reproducibility, and enable faster scientific and organizational decision-making. This talk describes some of the techniques needed to build systems like this at any organization.

Moderated Panel Discussion with Session Speakers

This panel examines how organizations scale automation and robotics through enterprise-ready architectures, governance frameworks, and operating models. Panelists will share practical strategies for sustaining transformation beyond pilots and early adopters, including approaches to change management, organizational alignment, and cross-site deployment. The discussion will focus on what it takes to institutionalize automated and robotic capabilities across teams, functions, and locations.

Moderator Synthesis and Closing Remarks

Best of Show Awards Reception in the Exhibit Hall with Poster Viewing

Unwind with colleagues at our lively reception! Explore posters, vote for the best, network with exhibitors, enjoy a drink, and try to win a raffle prize. Celebrate Best of Show winners!

Close of Day

Thursday, May 21

Registration Open

Continental Breakfast with Breakout Discussions

CONTINENTAL BREAKFAST WITH BREAKOUT DISCUSSIONS

Connect & Collaborate: Breakfast Networking Roundtables (Sponsorship Opportunities Available)

Kick off the morning with small-group roundtable discussions designed to spark collaboration, share challenges, and exchange insights across the Bio-IT community. Attendees gather around themed tables—spanning data ecosystems, AI adoption, foundational models, intelligent labs, translational infrastructure, and emerging technologies—to compare experiences and explore practical strategies. Each roundtable seats 8–10 participants for focused, peer-driven conversation that accelerates problem-solving, strengthens connections, and surfaces cross-functional perspectives before the plenary keynote. Topics will be announced throughout the year on the Bio-IT World website as part of our 2026 theme rollout, with opportunities for attendees and partners to propose table themes. If you have a topic to suggest or would like to participate as a moderator, contact Cindy Crowninshield at ccrowninshield@healthtech.com.

PLENARY KEYNOTE PROGRAM

Organizer's Remarks

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute , Executive Event Director , Cambridge Healthtech Institute

Bio-IT World 2026 Innovative Practices Awards Ceremony (Winners Announced)

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

The Innovative Practices Awards recognizes and celebrates technology innovation in the life sciences. Bio-IT World is currently accepting entries for the 2026 Innovative Practices Awards, a competition designed to recognize partnerships and projects pushing our industry forward. Winners will be announced in April 2026, recognized during the Thursday May 21 Plenary Keynote Program, and scheduled to give a podium presentation about their project during the conference. The deadline for entry is March 2, 2026. For more details about the Awards and to submit an application, visit www.bioitworldexpo.com/innovativepractices.

Bio-IT World 2026 Emerging Innovator Award—NEW (Winner Announced)

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

The Emerging Innovator Award recognizes one exceptional early-career researcher advancing the future of life sciences through breakthrough work in biomedical data, computational methods, or technology-enabled discovery. The 2026 awardee will deliver a 10-minute plenary keynote at Bio-IT World, highlighting the impact of their research and the forward-looking direction of their work. Nominations are due March 2, 2026, at www.bio-itworldexpo.com.

PLENARY KEYNOTE PRESENTATION:
Hopscotching through Drug Discovery: 15 Years of CADD and the Rise of AI

Photo of José Duca, PhD, Global Head Computer-Aided Drug Discovery, Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Inc. , Global Head Computer-Aided Drug Discovery , Global Discovery Chemistry , Novartis Institutes for BioMedical Research Inc
José Duca, PhD, Global Head Computer-Aided Drug Discovery, Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Inc. , Global Head Computer-Aided Drug Discovery , Global Discovery Chemistry , Novartis Institutes for BioMedical Research Inc

Coffee Break in the Exhibit Hall with Poster Competition Winners Announced (Sponsorship Opportunity Available)

Bio-IT is all about connections! Explore booths, award-winning posters, and network with clients, colleagues, and exhibitors. Grab coffee, build relationships, and stay for a chance to win a raffle prize!

Organizer's Remarks

AUTOMATION AS INFRASTRUCTURE: MODULAR, ROBOTIC, AND MULTIMODAL DISCOVERY PLATFORMS

Chairperson's Remarks

Leanna Duraj, Senior Account Manager, Thermo Fisher Scientific , Senior Account Manager , Thermo Fisher Scientific

Automation as Strategic Robotic Infrastructure for Integrated Discovery

Samuel Michael, Vice President, Data, Automation & Predictive Sciences (DAPS), GSK , VP , Data, Automation & Predictive Sciences (DAPS) , GSK

Modular Robotic Automation Architectures for Multi-Modality Workflows

Photo of Todd DeCollo, Principal Scientist, Alexion Pharmaceuticals, Inc. , Principal Scientist , Alexion Pharmaceuticals, Inc.
Todd DeCollo, Principal Scientist, Alexion Pharmaceuticals, Inc. , Principal Scientist , Alexion Pharmaceuticals, Inc.

Modular robotic automation is transforming labs from isolated workcells into orchestrated, modality-agnostic platforms spanning discovery and development. This talk details architectures that standardize labware and data, integrate robotics for conveyance and transportation, and unify high-level functions such as solid/liquid dispensing, mixing, incubation, sampling, and pH control. A recently deployed system will be presented as a case study, illustrating how orchestration, scheduling, and structured data pipelines accelerate DMTA (Design-Make-Test-Analyze), increase instrument utilization, enable remote monitoring and unattended operation, and lay the groundwork for AI-ready, closed-loop optimization and autonomous knowledge generation.

Aggregating Modular Robotics for a Multi-Detection DMTA Platform

Photo of Craig Shulz, PhD, Chief Platform Officer, Terray Therapeutics , Chief Platform Officer , Terray Therapeutics
Craig Shulz, PhD, Chief Platform Officer, Terray Therapeutics , Chief Platform Officer , Terray Therapeutics

Moderated Panel Discussion with Session Speakers

This panel explores the design of modular and flexible automation infrastructure that supports multi-modal discovery and heterogeneous robotic systems. Panelists will discuss platform extensibility, orchestration strategies, and approaches to balancing standardization with scientific flexibility. The discussion will highlight architectural patterns for building future-proof robotic platforms, integrating diverse instruments, and scaling automation across modalities without compromising adaptability or research velocity.

Moderator Synthesis and Closing Remarks

Session Break and Transition to Lunch

Refreshment Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)

Feeling tired? Recharge during the final Networking Exhibit Hall break! Visit booths, explore posters, connect with peers, and turn in your Game Cards for a chance to win a raffle prize.

AI IN THE LAB: TURNING ROBOTIC AND DIGITAL DATA INTO ACTIONABLE DECISIONS ACROSS THE DMTA CYCLE

Chairperson's Remarks

Kelcy Newell, PhD, Senior Director, Robotics and Automation Development, AstraZeneca , Senior Director , Robotics and Automation Development , AstraZeneca

Building AI-Ready Labs through Robotic Data Quality and Workflow Integration

Photo of Kelcy Newell, PhD, Senior Director, Robotics and Automation Development, AstraZeneca , Senior Director , Robotics and Automation Development , AstraZeneca
Kelcy Newell, PhD, Senior Director, Robotics and Automation Development, AstraZeneca , Senior Director , Robotics and Automation Development , AstraZeneca

Automated Data Capture and Metadata Frameworks in Robotic Workflows

Photo of Ilja Kusters, PhD, Associate Director, Assay Automation & Qualification, Generate:BioMedicines , Associate Director , Assay Automation & Qualification , Generate:BioMedicines
Ilja Kusters, PhD, Associate Director, Assay Automation & Qualification, Generate:BioMedicines , Associate Director , Assay Automation & Qualification , Generate:BioMedicines

AI-Enabled Iterative Experimentation Using Robotics at Scale

Photo of Pushkar Ghanekar, Senior Director – Lead, AI Frontier, Eli Lilly & Co. , Senior Director – Lead, AI Frontier , Lilly Research Laboratories , Eli Lilly & Co
Pushkar Ghanekar, Senior Director – Lead, AI Frontier, Eli Lilly & Co. , Senior Director – Lead, AI Frontier , Lilly Research Laboratories , Eli Lilly & Co

Moderated Panel Discussion with Session Speakers

This panel examines how high-quality data generated by automated and robotic laboratory systems enables AI-driven experiment planning, optimization, and closed-loop learning across the DMTA cycle. Panelists will discuss the technical and organizational requirements for AI-ready lab data, real-world examples of AI-enabled decision-making, and practical steps for progressing from automated execution to predictive and adaptive experimentation at scale.

Moderator Synthesis and Closing Remarks

Close of Conference


Register Now Image